Kendall Law Group Investigating IMS Health Inc. Takeover for Shareholders

November 6, 2009 3:20 PM ET
advertisement

Article tools

Stocks mentioned in this article
IMS Health Inc (RX) Stock Quote, Chart, News, Add to Watchlist

Kendall Law Group, founded by a former federal judge, began an investigation on behalf of IMS Health Inc. RX shareholders. The investigation concerns possible breaches of fiduciary duty by the Board of Directors in connection with the proposed acquisition by private equity firm Texas Pacific Group and the CPP Investment Board of Toronto. The transaction is valued at approximately $4 billion, including the assumption of debt.

According to the agreement, IMS shareholders will receive $22 in cash for each share owned, which is an almost 31% premium based on the closing price of IMS on November 4, 2009. Former federal judge Joe Kendall said, “The investigation concerns whether the consideration to be paid to shareholders is grossly unfair, inadequate, and substantially below the fair or inherent value of IMS and whether the directors and special committee members may have breached their fiduciary duties by not acting in the shareholders’ best interests in connection with the sale process.”

If you are a current holder of IMS stock and would like additional information concerning this proposed transaction, including your shareholder rights, contact Hamilton Lindley at 877-744-3728 or by email at hlindley@kendalllawgroup.com.

Kendall Law Group has substantial experience representing investors in mergers and acquisitions nationwide. Lawyers at the firm include a former United States Attorney, a former Dallas state and federal judge, and experienced securities lawyers.

Kendall Law Group, LLP
Hamilton Lindley, 214-744-3000
877-744-3728 Toll Free
214-744-3015 Facsimile
hlindley@kendalllawgroup.com
www.kendalllawgroup.com

Copyright 2009 Business Wire

Back to News by Industry

advertisement
MSN Money
Search MSN Money
Message Boards
Site Status